Fundraising Fox
/Companies
Sign in

Gandeeva

24 employees on LinkedIn · 7 known investors

Find your way into Gandeeva

Each arrow is one introduction. Sign up to fill in the first one.

525 people can intro you to Sriram

Ask Blair Willette to introduce you to Sriram Subramaniam

You →Blair · together at National Institutes of Health (NIH): Intramural Research Program (IRP) →Sriram

Sign up to find every way you can get introduced to Gandeeva

  • Your email: who you already know at Gandeeva, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Gandeeva team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.

AI & Machine LearningBiotechDeep TechDigital Health

Founders & leadership

SSSriram Subramaniam
Sriram SubramaniamFounder and CEO, Gandeeva Therapeutics Inc.Sriram Subramaniam is founder and CEO of Gandeeva Therapeutics, which applies cryo-electron microscopy and machine learning to drug discovery. He has over 20 years of experience in structural biology and has led structural biology research groups at the National Institutes of Health and the University of British Columbia.

Investors · 7

Lux Capitallisted by Lux CapitalNew York · $100K – $100M

How we know: Lux Capital's portfolio page · a partner's Signal profile · funding news · gandeeva.com · Not right? Tell us

Obvious Ventureslisted by Obvious VenturesSan Francisco · $250K – $6M

How we know: Obvious Ventures's portfolio page · funding news · gandeeva.com · the VCSheet dataset · Not right? Tell us

Amgen VenturesreportedThousand Oaks · $1M – $3M

How we know: funding news · gandeeva.com · Not right? Tell us

Amplitude Venture CapitalreportedMontreal

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Leaps by BayerreportedLeverkusen

How we know: funding news · gandeeva.com · Not right? Tell us

Also in the syndicate · 1

Amplitude Ventures

Funding

SEC filings, press & company announcements

$40M disclosed across 1 of 2 rounds · 2022

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Gandeeva Therapeutics raises $40 million in Series A funding to scale precision imaging techbetakit.com · Feb 2022Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions - Gandeeva Therapeuticsgandeeva.com · Jan 2022Gandeeva Therapeutics 2/5/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Gandeeva do?
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.
Who founded Gandeeva?
Gandeeva was founded by Sriram Subramaniam.
Who are Gandeeva's investors?
Gandeeva's investors include Air Street Capital, Lux Capital, Obvious Ventures, Amgen Ventures, Amplitude Venture Capital, Leaps by Bayer.
How much funding has Gandeeva raised?
Gandeeva has disclosed $40M raised across 1 of its 2 known rounds.